SynthesisInternational journal of molecular sciences2018

Meta-Analysis and Experimental Validation Identified FREM2 and SPRY1 as New Glioblastoma Marker Candidates.

Marko Vidak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.